G J Meissen, R H Myers, C A Mastromauro, W J Koroshetz, K W Klinger, L A Farrer, P A Watkins, J F Gusella, E D Bird, J B Martin. N Engl J Med 1988
Times Cited: 153
Times Cited: 153
Times Cited
Times Co-cited
Similarity
Presymptomatic diagnosis of delayed-onset disease with linked DNA markers. The experience in Huntington's disease.
J Brandt, K A Quaid, S E Folstein, P Garber, N E Maestri, M H Abbott, P R Slavney, M L Franz, L Kasch, H H Kazazian. JAMA 1989
J Brandt, K A Quaid, S E Folstein, P Garber, N E Maestri, M H Abbott, P R Slavney, M L Franz, L Kasch, H H Kazazian. JAMA 1989
49
A polymorphic DNA marker genetically linked to Huntington's disease.
J F Gusella, N S Wexler, P M Conneally, S L Naylor, M A Anderson, R E Tanzi, P C Watkins, K Ottina, M R Wallace, A Y Sakaguchi. Nature 1983
J F Gusella, N S Wexler, P M Conneally, S L Naylor, M A Anderson, R E Tanzi, P C Watkins, K Ottina, M R Wallace, A Y Sakaguchi. Nature 1983
49
The psychological consequences of predictive testing for Huntington's disease. Canadian Collaborative Study of Predictive Testing.
S Wiggins, P Whyte, M Huggins, S Adam, J Theilmann, M Bloch, S B Sheps, M T Schechter, M R Hayden. N Engl J Med 1992
S Wiggins, P Whyte, M Huggins, S Adam, J Theilmann, M Bloch, S B Sheps, M T Schechter, M R Hayden. N Engl J Med 1992
45
Predictive testing for Huntington disease: II. Demographic characteristics, life-style patterns, attitudes, and psychosocial assessments of the first fifty-one test candidates.
M Bloch, M Fahy, S Fox, M R Hayden. Am J Med Genet 1989
M Bloch, M Fahy, S Fox, M R Hayden. Am J Med Genet 1989
39
Predictive testing for Huntington disease: I. Description of a pilot project in British Columbia.
S Fox, M Bloch, M Fahy, M R Hayden. Am J Med Genet 1989
S Fox, M Bloch, M Fahy, M R Hayden. Am J Med Genet 1989
38
Predictive testing for Huntington disease in Canada: the experience of those receiving an increased risk.
M Bloch, S Adam, S Wiggins, M Huggins, M R Hayden. Am J Med Genet 1992
M Bloch, S Adam, S Wiggins, M Huggins, M R Hayden. Am J Med Genet 1992
28
Predictive testing for Huntington disease in Canada: adverse effects and unexpected results in those receiving a decreased risk.
M Huggins, M Bloch, S Wiggins, S Adam, O Suchowersky, M Trew, M Klimek, C R Greenberg, M Eleff, L P Thompson. Am J Med Genet 1992
M Huggins, M Bloch, S Wiggins, S Adam, O Suchowersky, M Trew, M Klimek, C R Greenberg, M Eleff, L P Thompson. Am J Med Genet 1992
27
Uptake of presymptomatic predictive testing for Huntington's disease.
D Craufurd, A Dodge, L Kerzin-Storrar, R Harris. Lancet 1989
D Craufurd, A Dodge, L Kerzin-Storrar, R Harris. Lancet 1989
27
26
Attitudes toward presymptomatic testing in Huntington disease.
C Mastromauro, R H Myers, B Berkman. Am J Med Genet 1987
C Mastromauro, R H Myers, B Berkman. Am J Med Genet 1987
22
On attitudes and appreciation 6 months after predictive DNA testing for Huntington disease in the Dutch program.
A Tibben, P G Frets, J J van de Kamp, M F Niermeijer, M Vegtervan der Vlis, R A Roos, H G Rooymans, G J van Ommen, F Verhage. Am J Med Genet 1993
A Tibben, P G Frets, J J van de Kamp, M F Niermeijer, M Vegtervan der Vlis, R A Roos, H G Rooymans, G J van Ommen, F Verhage. Am J Med Genet 1993
23
Attitudes of persons at risk for Huntington disease toward predictive testing.
S Kessler, T Field, L Worth, H Mosbarger. Am J Med Genet 1987
S Kessler, T Field, L Worth, H Mosbarger. Am J Med Genet 1987
21
DNA-testing for Huntington's disease in The Netherlands: a retrospective study on psychosocial effects.
A Tibben, M Vegter-van der Vlis, M I Skraastad, P G Frets, J J van der Kamp, M F Niermeijer, G J van Ommen, R A Roos, H G Rooijmans, D Stronks. Am J Med Genet 1992
A Tibben, M Vegter-van der Vlis, M I Skraastad, P G Frets, J J van der Kamp, M F Niermeijer, G J van Ommen, R A Roos, H G Rooijmans, D Stronks. Am J Med Genet 1992
28
A worldwide assessment of the frequency of suicide, suicide attempts, or psychiatric hospitalization after predictive testing for Huntington disease.
E W Almqvist, M Bloch, R Brinkman, D Craufurd, M R Hayden. Am J Hum Genet 1999
E W Almqvist, M Bloch, R Brinkman, D Craufurd, M R Hayden. Am J Hum Genet 1999
21
Psychological costs and benefits of predictive testing for Huntington's disease.
A M Codori, J Brandt. Am J Med Genet 1994
A M Codori, J Brandt. Am J Med Genet 1994
20
Three-year follow-up after presymptomatic testing for Huntington's disease in tested individuals and partners.
A Tibben, R Timman, E C Bannink, H J Duivenvoorden. Health Psychol 1997
A Tibben, R Timman, E C Bannink, H J Duivenvoorden. Health Psychol 1997
20
Exploration of the effects of predictive testing for Huntington disease on intimate relationships.
K A Quaid, M K Wesson. Am J Med Genet 1995
K A Quaid, M K Wesson. Am J Med Genet 1995
27
Testing for Huntington's disease with support for all parties.
A Tibben, M Vegter-vd Vlis, M F vd Niermeijer, J J Kamp, R A Roos, H G Rooijmans, P G Frets, F Verhage. Lancet 1990
A Tibben, M Vegter-vd Vlis, M F vd Niermeijer, J J Kamp, R A Roos, H G Rooijmans, P G Frets, F Verhage. Lancet 1990
48
Intended use of predictive testing by those at risk for Huntington disease.
G J Meissen, R L Berchek. Am J Med Genet 1987
G J Meissen, R L Berchek. Am J Med Genet 1987
19
Presymptomatic DNA-testing for Huntington disease: pretest attitudes and expectations of applicants and their partners in the Dutch program.
A Tibben, P G Frets, J J van de Kamp, M F Niermeijer, M Vegter-van der Vlis, R A Roos, G J van Ommen, H J Duivenvoorden, F Verhage. Am J Med Genet 1993
A Tibben, P G Frets, J J van de Kamp, M F Niermeijer, M Vegter-van der Vlis, R A Roos, G J van Ommen, H J Duivenvoorden, F Verhage. Am J Med Genet 1993
22
Ten years of presymptomatic testing for Huntington's disease: the experience of the UK Huntington's Disease Prediction Consortium.
P S Harper, C Lim, D Craufurd. J Med Genet 2000
P S Harper, C Lim, D Craufurd. J Med Genet 2000
19
Presymptomatic DNA testing for Huntington disease: identifying the need for psychological intervention.
A Tibben, H J Duivenvoorden, M Vegter-van der Vlis, M F Niermeijer, P G Frets, J J van de Kamp, R A Roos, H G Rooijmans, F Verhage. Am J Med Genet 1993
A Tibben, H J Duivenvoorden, M Vegter-van der Vlis, M F Niermeijer, P G Frets, J J van de Kamp, R A Roos, H G Rooijmans, F Verhage. Am J Med Genet 1993
25
Predictive testing for Huntington disease: nonparticipants compared with participants in the Dutch program.
I M van der Steenstraten, A Tibben, R A Roos, J J van de Kamp, M F Niermeijer. Am J Hum Genet 1994
I M van der Steenstraten, A Tibben, R A Roos, J J van de Kamp, M F Niermeijer. Am J Hum Genet 1994
18
Psychological effects of presymptomatic DNA testing for Huntington's disease in the Dutch program.
A Tibben, H J Duivenvoorden, M F Niermeijer, M Vegter-van der Vlis, R A Roos, F Verhage. Psychosom Med 1994
A Tibben, H J Duivenvoorden, M F Niermeijer, M Vegter-van der Vlis, R A Roos, F Verhage. Psychosom Med 1994
30
Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member.
J D Brook, M E McCurrach, H G Harley, A J Buckler, D Church, H Aburatani, K Hunter, V P Stanton, J P Thirion, T Hudson. Cell 1992
J D Brook, M E McCurrach, H G Harley, A J Buckler, D Church, H Aburatani, K Hunter, V P Stanton, J P Thirion, T Hudson. Cell 1992
18
Prediction of psychological functioning one year after the predictive test for Huntington's disease and impact of the test result on reproductive decision making.
M Decruyenaere, G Evers-Kiebooms, A Boogaerts, J J Cassiman, T Cloostermans, K Demyttenaere, R Dom, J P Fryns, H Van den Berghe. J Med Genet 1996
M Decruyenaere, G Evers-Kiebooms, A Boogaerts, J J Cassiman, T Cloostermans, K Demyttenaere, R Dom, J P Fryns, H Van den Berghe. J Med Genet 1996
17
A diagnostic interview: the schedule for affective disorders and schizophrenia.
J Endicott, R L Spitzer. Arch Gen Psychiatry 1978
J Endicott, R L Spitzer. Arch Gen Psychiatry 1978
17
Predictive testing for Huntington's disease: risk perception, reasons for testing and psychological profile of test applicants.
M Decruyenaere, G Evers-Kiebooms, A Boogaerts, J J Cassiman, T Cloostermans, K Demyttenaere, R Dom, J P Fryns, H Van den Berghe. Genet Couns 1995
M Decruyenaere, G Evers-Kiebooms, A Boogaerts, J J Cassiman, T Cloostermans, K Demyttenaere, R Dom, J P Fryns, H Van den Berghe. Genet Couns 1995
23
Age at onset in Huntington's disease: effect of line of inheritance and patient's sex.
R A Roos, M Vegter-van der Vlis, J Hermans, H M Elshove, A C Moll, J J van de Kamp, G W Bruyn. J Med Genet 1991
R A Roos, M Vegter-van der Vlis, J Hermans, H M Elshove, A C Moll, J J van de Kamp, G W Bruyn. J Med Genet 1991
20
The measurement of pessimism: the hopelessness scale.
A T Beck, A Weissman, D Lester, L Trexler. J Consult Clin Psychol 1974
A T Beck, A Weissman, D Lester, L Trexler. J Consult Clin Psychol 1974
16
Presymptomatic testing for huntington diseases: Recommendations for counseling.
K A Quaid. J Genet Couns 1992
K A Quaid. J Genet Couns 1992
48
Invited essay on the psychological aspects of genetic counseling. V. Preselection: a family coping strategy in Huntington disease.
S Kessler. Am J Med Genet 1988
S Kessler. Am J Med Genet 1988
28
Impact of Event Scale: a measure of subjective stress.
M Horowitz, N Wilner, W Alvarez. Psychosom Med 1979
M Horowitz, N Wilner, W Alvarez. Psychosom Med 1979
15
Unstable DNA sequence in myotonic dystrophy.
H G Harley, S A Rundle, W Reardon, J Myring, S Crow, J D Brook, P S Harper, D J Shaw. Lancet 1992
H G Harley, S A Rundle, W Reardon, J Myring, S Crow, J D Brook, P S Harper, D J Shaw. Lancet 1992
15
Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy.
J Buxton, P Shelbourne, J Davies, C Jones, T Van Tongeren, C Aslanidis, P de Jong, G Jansen, M Anvret, B Riley. Nature 1992
J Buxton, P Shelbourne, J Davies, C Jones, T Van Tongeren, C Aslanidis, P de Jong, G Jansen, M Anvret, B Riley. Nature 1992
15
Psychological impact of genetic testing for Huntington's disease: an update of the literature.
B Meiser, S Dunn. J Neurol Neurosurg Psychiatry 2000
B Meiser, S Dunn. J Neurol Neurosurg Psychiatry 2000
15
Improved predictive testing for Huntington disease by using three linked DNA markers.
M R Hayden, C Robbins, D Allard, J Haines, S Fox, J Wasmuth, M Fahy, M Bloch. Am J Hum Genet 1988
M R Hayden, C Robbins, D Allard, J Haines, S Fox, J Wasmuth, M Fahy, M Bloch. Am J Hum Genet 1988
29
Non-participation in predictive testing for Huntington's disease: individual decision-making, personality and avoidant behaviour in the family.
M Decruyenaere, G Evers-Kiebooms, A Boogaerts, T Cloostermans, J J Cassiman, K Demyttenaere, R Dom, J P Fryns, H Van den Berghe. Eur J Hum Genet 1997
M Decruyenaere, G Evers-Kiebooms, A Boogaerts, T Cloostermans, J J Cassiman, K Demyttenaere, R Dom, J P Fryns, H Van den Berghe. Eur J Hum Genet 1997
26
Adverse psychological events occurring in the first year after predictive testing for Huntington's disease. The Canadian Collaborative Study Predictive Testing.
K Lawson, S Wiggins, T Green, S Adam, M Bloch, M R Hayden. J Med Genet 1996
K Lawson, S Wiggins, T Green, S Adam, M Bloch, M R Hayden. J Med Genet 1996
22
Problems in genetic prediction for Huntington's disease.
M J Morris, A Tyler, L Lazarou, L Meredith, P S Harper. Lancet 1989
M J Morris, A Tyler, L Lazarou, L Meredith, P S Harper. Lancet 1989
34
Predicting adaptation to presymptomatic DNA testing for late onset disorders: who will experience distress? Rotterdam Leiden Genetics Workgroup.
A C DudokdeWit, A Tibben, H J Duivenvoorden, M F Niermeijer, J Passchier. J Med Genet 1998
A C DudokdeWit, A Tibben, H J Duivenvoorden, M F Niermeijer, J Passchier. J Med Genet 1998
18
Distress in individuals facing predictive DNA testing for autosomal dominant late-onset disorders: comparing questionnaire results with in-depth interviews. Rotterdam/Leiden Genetics Workgroup.
A C DudokdeWit, A Tibben, H J Duivenvoorden, M F Niermeijer, J Passchier, R W Trijsburg. Am J Med Genet 1998
A C DudokdeWit, A Tibben, H J Duivenvoorden, M F Niermeijer, J Passchier, R W Trijsburg. Am J Med Genet 1998
22
Partners of Huntington patients: implications of the disease and opinions about predictive testing and prenatal diagnosis.
G Evers-Kiebooms, A Swerts, H Van Den Berghe. Genet Couns 1990
G Evers-Kiebooms, A Swerts, H Van Den Berghe. Genet Couns 1990
58
Paradox of a better test for Huntington's disease.
A Maat-Kievit, M Vegter-van der Vlis, M Zoeteweij, M Losekoot, A van Haeringen, R Roos. J Neurol Neurosurg Psychiatry 2000
A Maat-Kievit, M Vegter-van der Vlis, M Zoeteweij, M Losekoot, A van Haeringen, R Roos. J Neurol Neurosurg Psychiatry 2000
22
Correlation between CTG trinucleotide repeat length and frequency of severe congenital myotonic dystrophy.
C Tsilfidis, A E MacKenzie, G Mettler, J Barceló, R G Korneluk. Nat Genet 1992
C Tsilfidis, A E MacKenzie, G Mettler, J Barceló, R G Korneluk. Nat Genet 1992
14
Instability versus predictability: the molecular diagnosis of myotonic dystrophy.
G K Suthers, S M Huson, K E Davies. J Med Genet 1992
G K Suthers, S M Huson, K E Davies. J Med Genet 1992
31
A highly polymorphic locus very tightly linked to the Huntington's disease gene.
J J Wasmuth, J Hewitt, B Smith, D Allard, J L Haines, D Skarecky, E Partlow, M R Hayden. Nature 1988
J J Wasmuth, J Hewitt, B Smith, D Allard, J L Haines, D Skarecky, E Partlow, M R Hayden. Nature 1988
14
25
Ethical issues policy statement on Huntington's disease molecular genetics predictive test. International Huntington Association. World Federation of Neurology.
L Went. J Med Genet 1990
L Went. J Med Genet 1990
13
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.